Regulatory Affairs Manager
in health
What a Regulatory Affairs Manager really does across UK pharma biotech medical devices and diagnostics plus salary skills and career paths.
A Regulatory Affairs Manager makes sure health and life-sciences products reach the market legally and safely, and stay compliant once they are there. In practical terms, the role owns the regulatory strategy and the day-to-day decisions that connect ambitious product or clinical development with the rules that govern medicines, devices, diagnostics and the data behind them. Whether the employer is a pharma company filing a marketing authorisation with the MHRA, a medical device maker preparing technical documentation for a notified body, a diagnostics lab validating an IVD, a contract research organisation supporting a sponsor, or a digital health scale-up classifying its software, the manager is the person who can say what is allowed, what needs evidence, and what would cross a line.
This role exists because these products affect clinical decisions, patient outcomes and sensitive data. Compliance is not a tick-box exercise at the end. Regulatory requirements shape product design, evidence generation, labelling, claims, manufacturing controls, post-market surveillance and how changes get released. A Regulatory Affairs Manager keeps the business moving quickly without creating patient risk, triggering enforcement action, or putting approvals and revenue in doubt.
Above all it is an ownership role. When the organisation wants to launch something new, enter a new market, change a formulation, update a device, retrain an algorithm or adjust a claim, this person is accountable for the regulatory position and for making sure leadership understands what is possible, what is risky, and what has to change to stay compliant.
How this role differs in health and life sciences
In many sectors, the cost of being wrong is commercial: lost customers, a bruised reputation, maybe a contractual dispute. In health and life sciences the cost of being wrong can include patient harm, a product recall, a field safety corrective action, withdrawal from a market, and legal exposure, usually with regulators, auditors and procurement teams scrutinising the decisions afterwards.
That changes how a Regulatory Affairs Manager works. They do not just interpret requirements, they help define what the product is allowed to be. Decisions on intended use, classification, clinical claims, evidence thresholds, data handling and release governance tend to be more constrained, more documented and harder to reverse than in a typical software business.
The compliance picture is rarely a single framework. A pharmaceutical product sits under MHRA licensing and Good Manufacturing Practice. A medical device or IVD sits under the UK medical device regulations and quality management to ISO 13485, with clinical evaluation and post-market surveillance running in parallel. Software as a medical device adds change-control questions that a pharma product never faces. Clinical studies pull in Good Clinical Practice and Health Research Authority approvals. Behind all of it sit the buyers: NHS trusts and private providers who expect credible evidence and clean documentation before they will adopt anything. The Regulatory Affairs Manager is often the connective tissue that stops a locally sensible decision from becoming a global regulatory problem later.
Core responsibilities in health and life sciences
Day to day, the Regulatory Affairs Manager owns how the organisation moves through regulatory pathways while still hitting development and commercial timelines. They set regulatory strategy for new products and significant changes, define what evidence is needed to support intended use and claims, and keep submissions and lifecycle documentation coherent as the product evolves.
- Shape the regulatory strategy for new products, variations and major changes, and pick the route to approval that fits the product and the market.
- Prepare, review and submit regulatory filings: marketing authorisations and variations for medicines, technical documentation and conformity assessment for devices and IVDs, clinical trial or investigation applications, and responses to regulator questions.
- Decide what counts as enough evidence for performance, safety and claims, then hold that line with R&D, clinical and commercial teams before money is spent the wrong way.
- Run change control so frequent updates, whether a manufacturing change or a software release, do not create silent compliance drift that surfaces as an audit finding.
- Own post-market obligations: complaints handling, vigilance and adverse-event reporting, surveillance, trending and corrective actions, treated as live duties rather than afterthoughts.
- Keep registrations, labelling and product information accurate and current, and make sure promotional material stands up against the relevant codes.
- Translate regulatory constraints and options into plain language for executives, and into practical guardrails for delivery teams.
A large part of the job is trade-off management under constraint. When commercial wants speed, the manager decides what can be accelerated safely and defensibly, what must wait for evidence, and what needs a design change to avoid a heavier classification or a longer approval. In smaller companies this role often blends into quality, and the manager may be the person building the processes that later scale into a dedicated QA and RA function.
Skills and competencies for health and life sciences
| Core skill | What it looks like in health and life sciences | Why it matters |
|---|---|---|
| Regulatory judgement | Taking ambiguous product reality (a formulation, a device design, software behaviour, a clinical workflow) and turning it into a defensible regulatory position | Prevents over-claiming and under-controlling, both of which can block market access or trigger regulator action |
| Framework fluency | Working knowledge of MHRA licensing, UK device regulations, ISO 13485, GMP, GCP and HRA approvals, applied to the right product type | Stops costly misclassification and keeps filings credible with regulators and notified bodies |
| Evidence thinking | Setting clear expectations for what good enough means on performance, safety and claims, in context | Avoids expensive late-stage rework and supports adoption by NHS and private buyers |
| Cross-functional leadership | Influencing R&D, clinical, quality, engineering and commercial teams without relying on authority | Regulatory constraints only work when they are built into real delivery plans, not parked in a document |
| Lifecycle ownership | Treating approval as the start, not the finish: managing changes, incidents and surveillance continuously | Protects the organisation from drift as products evolve and new risks appear |
| Documentation and traceability | Insisting on a clean thread between requirements, risks, testing, claims and post-market inputs without drowning delivery in process | Creates audit-ready coherence that supports scale, partnerships and procurement confidence |
| Stakeholder communication | Explaining constraints and options to executives and delivery teams in practical terms | Enables faster decisions, fewer surprises and a clearer shared view of risk appetite |
Salary ranges in UK health and life sciences
Pay for Regulatory Affairs Managers is driven less by the job title and more by the risk and accountability you carry: device classification or clinical impact, whether you own strategy or execute it, the complexity of submissions and lifecycle change, how mature the quality system is, and whether you are the only regulatory leader in the business. Setting matters too. Established pharma and medical device employers tend to pay above early-stage scale-ups for the same nominal level, and medical device regulatory talent is in short supply, which pushes packages up. Location plays a part, with the strongest clusters in London, the M4 corridor, Oxford and Cambridge, but scope and regulatory criticality often matter more.
| Experience level | Estimated annual salary range | What drives compensation |
|---|---|---|
| Junior | London & South East: £32,000–£45,000 Rest of UK: £30,000–£42,000 | Officer or associate work supporting submissions and documentation; growing exposure to regulated development; intensity of detail |
| Mid-level | London & South East: £45,000–£62,000 Rest of UK: £42,000–£56,000 | Owning submissions or product components, managing change-control inputs, acting as a key internal contact, handling higher-impact products |
| Senior | London & South East: £62,000–£85,000 Rest of UK: £56,000–£78,000 | End-to-end ownership of a product line, stronger strategic input, more independence with regulators and auditors, accountability for post-market outcomes |
| Lead | London & South East: £80,000–£110,000 Rest of UK: £70,000–£98,000 | Setting strategy across products and markets, leading cross-functional decisions, mentoring a team, carrying single-point-of-failure accountability |
| Head / Director | London & South East: £105,000–£160,000 Rest of UK: £92,000–£140,000 | Owning the regulatory function (often with QA scope), representing the company externally, board-level risk ownership, leading audits and resourcing |
Sources: Prospects regulatory affairs profile (early-career £30,000–£45,000, experienced £45,000–£85,000, associate director and director £80,000–£160,000); Glassdoor UK (Regulatory Affairs Manager average around £47,000 with a typical band near £38,000–£60,000); plus live Reed and Michael Page UK postings and salary commentary. Treat these as a guide; real offers move with employer, setting and specialism.
Beyond base salary, many employers add a performance bonus (modest at junior levels, more meaningful at senior and leadership), plus pension and private medical cover. Equity is more common in start-ups and scale-ups, usually as options rather than public-company stock, and its value swings with stage and risk. On-call is not standard for regulatory roles, though some organisations add compensation where leaders are expected to be reachable for urgent vigilance escalations, field safety actions or time-critical regulator interactions. Where that expectation exists, total pay tends to be higher.
Career pathways
Most people enter regulatory careers from life sciences, medical devices, clinical research, pharmacy, quality or technical writing, often starting as a regulatory affairs assistant, associate or officer and then widening their scope. Moving across from QA into regulatory is common too, especially in smaller companies where the line between quality-system ownership and regulatory delivery is thin. Professional development through TOPRA, including its postgraduate qualifications and registered-member route, is a recognised marker as you progress.
Progression happens when you move from contributing to the file to owning the regulatory position. Early growth looks like taking responsibility for defined deliverables and learning how decisions are justified. Mid-career growth is about becoming the person who can choose an approach, defend it and coordinate the organisation around it, especially when commercial pressure is high.
Senior and lead progression is less about volume and more about breadth and consequence: managing product portfolios, owning strategy across markets, building governance that holds up under continuous change, and leading external interactions with regulators and notified bodies. Head and Director roles expand into organisational design: setting risk appetite, resourcing the function, integrating regulatory into how the business operates, and being accountable for regulatory outcomes as a business constraint rather than a support service. From there, some move into consultancy or contract work, which many organisations rely on for specialist regulatory expertise.
FAQ
If I am coming from pharma regulatory, what changes when I move to devices or digital health?
Expect faster iteration and more change-driven work. Device and software-led products release updates far more often than a licensed medicine, so strong change-control thinking and cross-functional influence become as important as classic submission expertise. The framework also shifts: ISO 13485, clinical evaluation and conformity assessment replace much of the marketing-authorisation machinery you know.
Will I be expected to own quality as well as regulatory?
In many smaller companies, yes, at least partially. Even when QA and RA are separate on paper, regulatory decisions depend on whether the quality system, risk management and post-market processes are credible and audit-ready.
How do interviewers evaluate a Regulatory Affairs Manager?
They look for judgement under constraint: how you classify products, set intended-use boundaries, decide evidence thresholds and handle trade-offs without creating hidden risk. You will usually be tested on how you communicate with R&D, clinical and commercial teams, and how you respond when a timeline collides with a compliance requirement.
Find your next role
Ready to own regulatory outcomes across pharma, devices, diagnostics or digital health? Search Regulatory Affairs Manager roles on Meeveem and find a team where compliance moves the work forward rather than holding it back.